Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8UCN

Komagataella pastoris Cytochrome c oxidase in complex with human VMAT2 and Histamine

8UCN の概要
エントリーDOI10.2210/pdb8ucn/pdb
EMDBエントリー42132
分子名称Synaptic vesicular amine transporter, Cytochrome c oxidase subunit 9, HISTAMINE, ... (16 entities in total)
機能のキーワードvmat, slc18, vascular monoamine transporter, cytochrome c oxidase-vmat2 complex, neurotransmitters, histamine, membrane protein
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数10
化学式量合計234925.42
構造登録者
Ye, J.,Liu, B.,Li, W. (登録日: 2023-09-26, 公開日: 2024-10-09, 最終更新日: 2026-04-22)
主引用文献Ye, J.,Chen, H.,Ammerman, A.,Wang, Y.,Wang, K.,Xu, J.,Liu, B.,Li, W.
Molecular basis of vesicular monoamine transport and neurological drug interactions.
Cell Rep, 44:116490-116490, 2025
Cited by
PubMed Abstract: Vesicular monoamine transporter 2 (VMAT2) stores monoamine neurotransmitters in synaptic vesicles to regulate their release. VMAT2 is a primary target in neurological disorder treatment and contributes to amphetamine-induced psychostimulation. Here, we report cryo-electron microscopy structures of human VMAT2 capturing a cytoplasmic-open state with reserpine and lumenal-facing states with serotonin and histamine in open, amphetamine in less open, tetrabenazine in fully occluded, and unbound VMAT2 in partially occluded conformations. This structural flexibility facilitates tetrabenazine binding and proton-driven monoamine accumulation. VMAT2 binds serotonin and histamine in opposite orientations through two negatively charged sites, one functioning in protonation. Amphetamine binds in the same pocket without engaging this protonation site. Liposome-based analyses demonstrate that amphetamine directly induces the release of a fluorescent monoamine analog via VMAT2, consistent with an exchange mechanism underlying psychostimulation. These findings reveal the molecular basis of monoamine storage and drug interactions by VMAT2, informing therapeutic development for neurological diseases and substance abuse.
PubMed: 41166311
DOI: 10.1016/j.celrep.2025.116490
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (3.31 Å)
構造検証レポート
Validation report summary of 8ucn
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon